JAMES V CARUSO
CIK 1202770 · President & CEO · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$50.8K
Companies
5
Total Filings
36
Lifetime Open-Market Net
-$2.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLRB | President & CEO | 20,318 | $2.50 | $50.8K | $74.9K | 8 | 2026-07-08 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | President and CEO | 86,401 | $0.12 | $10.3K | $45.1K | 10 | 2021-03-05 |
| Cellectar Biosciences, Inc. (CLRB.W) Delisted | President and CEO | 6,000 | — | — | $8.3K | 4 | 2016-05-23 |
| Cellectar Biosciences, Inc. (CLRB.Z) Delisted | President and CEO | 47,548 | — | — | $99.5K | 1 | 2016-04-21 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | Chief Commercial Officer | 103,659 | — | — | -$2.97M | 13 | 2010-03-03 |
Recent Filings · Page 3 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-11-25 | Cellectar Biosciences, Inc. (CLRB.W) Delisted | Buy (P) | +1,000 | $1.3K | EDGAR |
| 2015-11-24 | Cellectar Biosciences, Inc. (CLRB.W) Delisted | Buy (P) | +1,000 | $1.2K | EDGAR |
| 2015-11-19 | Cellectar Biosciences, Inc. (CLRB.W) Delisted | Buy (P) | +4,000 | $5.8K | EDGAR |
| 2010-03-03 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Mixed | −37,500 | -$504.9K | EDGAR |
| 2010-02-24 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Mixed | +52,286 | -$44.4K | EDGAR |
| 2009-08-12 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Mixed | — | -$427.0K | EDGAR |
| 2009-08-05 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Mixed | — | -$306.0K | EDGAR |
| 2009-06-17 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Sell (S) | −27,500 | -$223.9K | EDGAR |
| 2009-03-27 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Mixed | — | -$195.2K | EDGAR |
| 2009-03-16 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Mixed | — | -$214.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.